RUBY
Rubius Therapeutics, Inc
RUBY
RUBY
Delisted
RUBY was delisted on the 6th of March, 2023.
117 hedge funds and large institutions have $494M invested in Rubius Therapeutics, Inc in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 39 increasing their positions, 33 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
117
Holders Change
+9
Holders Change %
+8.33%
% of All Funds
1.85%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
21
Increased
39
Reduced
33
Closed
12
Calls
$4.78M
Puts
$556K
Net Calls
+$4.23M
Net Calls Change
+$4.23M
Top Buyers
Top Sellers
| 1 |
1
State Street
Boston,
Massachusetts
|
$5.48M |
| 2 |
2
Vanguard Group
Malvern,
Pennsylvania
|
$12.8M |
| 3 |
3
Rafferty Asset Management
New York
|
$0 |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$3K |
| 5 |
5
Citigroup
New York
|
$177K |
